Corrigenda - Corporate Governance Reports 2022 and 2023 General Announcement Filing viewer · member access Original SGX announcement
Press Release - iX Biopharma Introduces MeltMed in USA General Announcement Filing viewer · member access Original SGX announcement
Annual Reports and Related Documents:: Annual Reports and Related Documents Filing viewer · member access Original SGX announcement
Full Yearly Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
Press Release - iX Biopharma Develops Sublingual Interferon General Announcement Filing viewer · member access Original SGX announcement
Proposed Issuance of Convertible Bonds of An Aggregate Principal Amount of S$2,000,000 - Completion General Announcement Filing viewer · member access Original SGX announcement
Proposed Issuance of Convertible Bonds of S$2,000,000 - Receipt of Listing and Quotation Notice General Announcement Filing viewer · member access Original SGX announcement
Proposed Issuance of Convertible Bonds of an Aggregate Principal Amount of S$2,000,000 General Announcement Filing viewer · member access Original SGX announcement
Half Yearly Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
Press Release: iX Biopharma Successfully Completes Phase 1 Sublingual Dexmedetomidine Clinical Study General Announcement Filing viewer · member access Original SGX announcement
Reconstitution of the Board Committees General Announcement Filing viewer · member access Original SGX announcement
Minutes of Annual General Meeting Held on 14 October 2022 General Announcement Filing viewer · member access Original SGX announcement
Appointment of Independent Non-Executive Director Change - Announcement of Appointment Filing viewer · member access Original SGX announcement
Appointment of Independent Non-Executive Director and Re-Constitution of the Board General Announcement Filing viewer · member access Original SGX announcement
Grant of Share Awards Pursuant to iX Performance Share Plan Employee Stock Option/ Share Scheme Filing viewer · member access Original SGX announcement
IX BIOPHARMA WINS BEST CBD SUBLINGUAL EDIBLE AWARD General Announcement Filing viewer · member access Original SGX announcement
Retirement of Independent and Non-Executive Director - Mr Low Weng Keong Change - Announcement of Cessation Filing viewer · member access Original SGX announcement
Annual Reports and Related Documents:: Annual Reports and Related Documents Filing viewer · member access Original SGX announcement
Press Release - Launch of Sublingual Dexmedetomidine Programme General Announcement Filing viewer · member access Original SGX announcement
Full Yearly Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
PROPOSED PLACEMENT OF 13,710,000 NEW ORDINARY SHARES - ALLOTMENT AND ISSUE OF SUBSCRIPTION SHARES Placements Filing viewer · member access Original SGX announcement
